… in atrial fibrillation, all directly targeting specific components in the coagulation cascade.These
include a direct thrombin inhibitor, dabigatran etexilate, … In a Greek study, the presence of …

… Economic evaluation of warfarin, dabigatran, rivaroxaban, and apixaban for stroke prevention
in atrial fibrillation… Economic evaluation of dabigatran etexilate for the prevention of venous …

… frequency of atrial fibrillation between treatment arms. … , Evaluation in secondary Stroke
Prevention comparing the EfficaCy and safety of the oral Thrombin inhibitor dabigatran etexilate …

… This economic analysis indicates that treatment with clopidogrel for secondary prevention of
… is a cost-effective antiplatelet treatment over aspirin in a Greek third-party payer perspective. …

… Non-valvular atrial fibrillation (AF) patients on DOAC … Greece were invited to participate.
This project was part of the validation study of the Greek version of the Jessa Atrial fibrillation …

… dabigatran) or activated factor X (FXa) (rivaroxaban, apixaban and edoxaban) have been
marketed for a number of indications related to prophylaxis and treatment … This review includes …

… (Larissa, Greece) where the pooled analysis was performed. The … Source) will compare
dabigatran etexilate and rivaroxaban, … ESC Guidelines for the management of atrial fibrillation: an …

… to the main analysis, we will perform three sensitivity analyses for the primary endpoint. Firstly,
we will perform a survival analysis of the … Thirdly, we will perform an on-treatment analysis. …

… In this review, the authors aim to discuss the differences in techniques, safety, efficacy, and
… the Amplatzer Amulet TM for stroke prevention in atrial fibrillation: the first case in Greece. …

… (Larissa, Greece) where the pooled analysis was performed. … oral Thrombin inhibitor dabigatran
etexilate vs. acetylsalicylic … 2016 ESC Guidelines for the management of atrial fibrillation …